Vinkit SARS-CoV-2 Multiplex RT-PCR developed by Vinmec.

The difference between the 2 sets - VinKit SARS-CoV-2 RT-PCR 1.0 and VinKit SARS-CoV-2 Multiplex RT-PCR - is the implementation process. While the VinKit SARS-CoV-2 RT-PCR 1.0 kit is operated with three independent reactions to confirm the results, the VinKit SARS-CoV-2 Multiplex RT-PCR set combines three independent reactions into one to save biology products, time, and costs, while minimizing operational steps and technical errors.

According to Dr. Nguyen Thanh Liem, Director of the Vinmec Research Institute of Stem Cell and Gene Technology, the VinKit SARS-CoV-2 Multiplex RT-PCR kit is capable of integrating the “3 in 1” reaction, reducing two thirds of the technical steps, increasing the testing speed by 2 times compared to other commercially available kits while ensuring high accuracy with low cost.

Vinmec developed the 2 test kits based on the technological process of the US Centers for Disease Control and Prevention (US CDC), approved by the FDA (US Food and Drug Administration) in March. Independent testing results from Vietnam's National Institute of Hygiene and Epidemiology and the National Institute for Vaccines and Biologicals show that the 2 sets of Vinkit are stable, 100% accurate on clinical samples, equivalent to the diagnostic bio-products recommended by the WHO.